Search for: "WYETH LLC" Results 1 - 20 of 221
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Mar 2024, 12:46 pm by admin
Wyeth-Ayerst Laboratories Co., 278 F.Supp.2d 684, 700 (W.D.N.C. 2003) (expert witnesses may not opine about corporate intent and motive) (barring Dr. [read post]
28 Nov 2023, 5:24 am by Guest Author
 United Technologies Corp., 487 U.S. 500 (1988) Wyeth v. [read post]
19 Mar 2022, 2:09 pm by admin
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
6 Dec 2021, 3:25 pm by Sabrina I. Pacifici
Wyeth LLC, 562 U.S. 223 (2011), Justice Antonin Scalia stated that “the elimination of communicable diseases through vaccination became one of the greatest achievements of public health in the 20th century. [read post]
Wyeth LLC, IP High Court Case No. 2020 (Gyo-Ke) 10015; Decision date: May 17, 2021) filed by Merck Sharp & Dohme (“MSD”) as an appeal from a JPO trial decision holding Wyeth’s patent valid. [read post]
Wyeth LLC, IP High Court Case No. 2020 (Gyo-Ke) 10015; Decision date: May 17, 2021) filed by Merck Sharp & Dohme (“MSD”) as an appeal from a JPO trial decision holding Wyeth’s patent valid. [read post]
9 Oct 2021, 9:48 am by Juvan Bonni
Recent Headlines in the IP World: Ahmar Khan: Canada Lacks ‘Political Will’ to Waive COVID-19 Vaccine Patents, Bolivian Minister Says (Source: Global News) Andreas Curkovic: Psygen Announces That Psilocybin from Its Patent-Pending Process Has Been Used in Human Trial (Source: Yahoo Finance) Blake Brittain: Apple Loses (and Wins) Rulings in ‘Home Button’ Patent Dispute (Source: Reuters) Scott French: N2 Packaging Systems, LLC Expands its Global Patent… [read post]
29 Mar 2021, 7:10 pm by admin
In one Fen-Phen case, one plaintiff sought to retain an expert witness previously retained by Wyeth to testify about the same diet drug (fenfluramine) in a case brought by a different plaintiff. [read post]
15 Nov 2020, 6:44 am by Magdaleen Jooste
The judgement was on the case between Merck Sharp & Dohme Limited (“MSD”) and Wyeth LLC’s (“Wyeth”). [read post]
12 Nov 2020, 5:55 am by Jon L. Gelman
McCabe today announced the filing of two lawsuits to compel the clean-up of contamination and recover Natural Resource Damages (NRDs).The first suit is against Solvay Specialty Polymers USA, LLC and Arkema Inc., two companies responsible for widespread contamination from toxic per- and polyfluoroalkyl substances (PFAS)  emanating from a Gloucester County facility, which has contaminated public drinking water in the region. [read post]
2 Nov 2020, 2:00 am by Emma Irwin (Bristows)
Merck Sharp & Dohme Limited (MSD) sought to invalidate Wyeth LLC’s (Wyeth) patent, EP (UK) 2 676 679 (the ‘Patent’), with Wyeth maintaining that the Patent was valid and counterclaiming for infringement on a quia timet basis in relation to MSD’s V114 product. [read post]
30 Oct 2020, 6:34 pm
Electron Microscope Image of Human BloodPhotographers: Bruce Wetzel and Harry SchaeferJane LambertPatents Court (Mr Justice Meade) Merck Sharp & Dohme Ltd v Wyeth LLC [2020] EWHC 2636 (Pat) (15 Oct 2020) This was an action by Merck Sharp & Dohme Ltd ("MSD") for the revocation of European Patent (UK) 2,676,679 for formulations which stabilize and inhibit precipitation of immunogenic compositions [read post]
28 May 2020, 5:29 am by Schachtman
Another vacuous response to a methodological challenge under Rule 702 is to label the challenge as “going to the weight, not the admissibility” of the challenged expert witness’s testimony. [read post]